Laboratorial findings of Streptococcus keratitis and conjunctivitis;Características laboratoriais das ceratites e conjuntivites causadas por Streptococcus sp

Arquivos Brasileiros de Oftalmologia

Volumn 67, Issue 5, 2004, Pages 781-784

  Solari, Helena Parente ^a   De Sousa, Luciene Barbosa ^a   De Freitas, Denise ^a   Yu, Maria Cecília Zorat ^a   Höfling Lima, Ana Luisa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibacterial agents therapeutic use; Conjunctivitis, bacterial drug therapy; Conjunctivitis, bacterial microbiology; Eye infections, bacterial microbiology; Fluoroquinolones therapeutic use; Keratitis drug therapy; Keratitis microbiology; Quinolones therapeutic use; Streptococcus pneumoniae isolation purification; Viridans, streptococci isolation purification

Indexed keywords

EID: 69549121539     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492004000500016     Document Type: Article

References (16)

1. Höfling-Lima AL, Belfort Jr R. Ceratites bacterianas. In: Belfort Jr R, Kara-José N. Córnea clínica-cirúrgica. São Paulo: Roca; 1996. p.181-188
2. Alves MR, de Andrade BBA. Úlcera de córnea bacteriana. Arq Bras Oftalmol. 2000;63(6):495-501.
3. Liesegang TJ. Bacterial keratitis. In: Kaufman HE, Barron BA, McDonald MB. The cornea. Boston: Butterworth-Heinemann; 1997. p.159-218.
4. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001;85(7): 842-847
5. Medeiros MIC, Neme SN, Da Silva P, Silva JO, Carneiro AMM, Carloni MC, Brandileone MCC. Streptococcus pneumoniae and Haemophilus influenzae as etiological agents of conjunctivitis outbreaks in the region of Ribeirão Preto, SP, Brazil. Rev Inst Med Trop. 1998;40(1):11-16
6. Block SL, Hedrick J, Tyler RE, Smith A, Findlay R, Keegan E, et al. Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998). Antimicrob Agents Chemoter. 2000;44(6):1650-1654
7. Honig MA, Cohen EJ, Rapuano CJ, Laibson PR. Corneal ulcers and the use of topical fluoroquinolones. CLAO J. 1999;25(4):200-203
8. Graves A, Henry M, O'Brien TP, Hwang DG, Buskirk AV, Trousdale MD. In vitro susceptibility of bacterial ocular isolates to fluoroquinolones. Cornea 2001;20(3):301-5.
9. Erratum in: Cornea. 2001;20(5);546.
10. Höfling-Lima AL, Moeller CTA, Yu MCZ, Branco BC, Farah ME. Microbiological efficacy of lomefloxacin and other drugs regarding microorganisms isolated from the human conjunctiva. Arq Bras Oftalmol. 2001;64(2): 147-151
11. Uesugui E, Cypel-Gomes MC, Atique D, Goulart DG, Galluci FR, Nishiwaki-Dantas MC, et al. Identificação laboratorial dos patógenos oculares mais freqüentes e sua susceptibilidade in vitro aos agentes antimicrobianos. Arq Bras Oftalmol. 2002;65(3):339-342
12. Knauf HP, Silvany R, Southern PM, Risser RC, Wilson SE. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea. 1996;15(1): 66-70.
13. Kowalski RP, Karenchak LM, Gordon YJ. Comparison of ciprofloxacin and ofloxacina using human corneal susceptibility levels. Cornea. 1998;17(3):282-287
14. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis. A 5-year review. Ophthalmology. 1999;106(7):1313-1318
15. Kowalski RP, Romanowski EG, Yates KA, Gordon YJ. Lomefloxacin is an effective treatment of experimental bacterial keratitis. Córnea. 2001;20(3):306-308
16. Smith A, Pennefather PM, Kaye SB, Hart CA. Fluoroquinolones. Place in ocular therapy. Drugs. 2001;61(6):747-761